Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lynch

Showing results (901-910 of 929) with videos related to

Pageof 93
Sort By:
International Journal of Cancer|May 19, 2005
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
The New England Journal of Medicine|December 17, 2008
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndromeJohn Burn, D Timothy Bishop, Jukka-Pekka Mecklin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 10, 2015
PMS2 monoallelic mutation carriers: the known unknownMcKinsey L Goodenberger, Brittany C Thomas, Douglas Riegert-Johnson, et al.
The Breast Journal|January 15, 2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Journal of Medicinal Chemistry|March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A InhibitorsStephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
European Journal of Neurology|August 18, 2015
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patientsO Lorenzo-Betancor, K Ogaki, A I Soto-Ortolaza, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
British Journal of Cancer|June 26, 2008
Rapid progression of prostate cancer in men with a BRCA2 mutationS A Narod, S Neuhausen, G Vichodez, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 7, 2008
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyTadeusz Majewski, Sangkyou Lee, Joon Jeong, et al.
Pageof 93

Showing results (901-910 of 929) with videos related to

Sort By:
Pageof 93
International Journal of Cancer|May 19, 2005
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
The New England Journal of Medicine|December 17, 2008
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndromeJohn Burn, D Timothy Bishop, Jukka-Pekka Mecklin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 10, 2015
PMS2 monoallelic mutation carriers: the known unknownMcKinsey L Goodenberger, Brittany C Thomas, Douglas Riegert-Johnson, et al.
The Breast Journal|January 15, 2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Journal of Medicinal Chemistry|March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A InhibitorsStephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
European Journal of Neurology|August 18, 2015
DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patientsO Lorenzo-Betancor, K Ogaki, A I Soto-Ortolaza, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
British Journal of Cancer|June 26, 2008
Rapid progression of prostate cancer in men with a BRCA2 mutationS A Narod, S Neuhausen, G Vichodez, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 7, 2008
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyTadeusz Majewski, Sangkyou Lee, Joon Jeong, et al.
Pageof 93